Dono Mariella, Cerruti Giannamaria, Zupo Simona
S. C. Oncologia Medica C, Istituto Nazionale per la Ricerca sul Cancro, IST, L.go Rosanna Benzi, n. 10, 16132 Genova, Italy.
Int J Biochem Cell Biol. 2004 Nov;36(11):2105-11. doi: 10.1016/j.biocel.2004.05.017.
In the last two decades, many efforts have been made to better understand the biology of B-lymphoproliferative disorders through the knowledge of physiology and function of the postulated normal counterpart. The follicular mantle B-cells express a typical CD23+ IgM+ IgD+ phenotype and surround the germinal center area in secondary lymphoid organs. CD5+ B-cells with FM phenotype can be isolated from different sources and all share similar morphologic, phenotypic and functional features (small cells, scanty nucleus/cytoplasm ratio, unmutated VH genes, response to polyclonal activators but not to T independent antigens, production of "natural" antibodies). While the CD5+ B-cells predominate in fetal life, their number decreases with age. However, the CD5+ B-cells have been demonstrated to increase again in elderly both in man and mouse. This finding may explain the incidence of B-CLL and of MCL that are believed to represent the malignant transformation of the normal CD5+ B-cells, among elderly and middle aged individuals, respectively.
在过去二十年中,人们通过了解假定的正常对应物的生理学和功能,做出了许多努力来更好地理解B淋巴细胞增殖性疾病的生物学特性。滤泡套B细胞表达典型的CD23+ IgM+ IgD+表型,并围绕次级淋巴器官中的生发中心区域。具有FM表型的CD5+ B细胞可从不同来源分离得到,且都具有相似的形态、表型和功能特征(小细胞、核质比低、VH基因未突变、对多克隆激活剂有反应但对非T细胞依赖性抗原无反应、产生“天然”抗体)。虽然CD5+ B细胞在胎儿期占主导地位,但其数量随年龄增长而减少。然而,已证明在人和小鼠的老年人中,CD5+ B细胞数量会再次增加。这一发现可能解释了B-CLL和MCL的发病率,它们分别被认为是正常CD5+ B细胞在老年人和中年个体中的恶性转化。